George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 21,129 shares at $960.57 ($20.4M) on 2026-11-02, disclosed to the SEC on 2026-11-04.
Seasonal sale ($20.4M) by Director — this insider has traded REGN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $960.57 | 1,224 | $1.2M | 5.8% |
| 2 | $961.85 | 540 | $519K | 2.5% |
| 3 | $962.61 | 2,522 | $2.4M | 11.9% |
| 4 | $963.47 | 4,338 | $4.2M | 20.5% |
| 5 | $964.57 | 2,670 | $2.6M | 12.6% |
| 6 | $965.38 | 7,073 |
| $6.8M |
| 33.5% |
| 7 | $966.27 | 1,522 | $1.5M | 7.2% |
| 8 | $967.07 | 1,040 | $1.0M | 4.9% |
| 9 | $970.18 | 200 | $194K | 1.0% |
| Total | $964.38 avg | 21,129 | $20.4M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |